[1]
Hassan Metwally, M.A. et al. 2014. Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC). Acta Oncologica. 53, 5 (May 2014), 654–661. DOI:https://doi.org/10.3109/0284186X.2013.864050.